54 results
8-K
EX-10.3
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
(“Company”) is pleased that you have agreed to join the Board as a non-executive director and to serve as a member of the Board's Corporate Governance … in, and perform your role as a non-executive, independent director and as a member of the Board's Corporate Governance and Nominating Committee from
424B3
ADAP
Adaptimmune Therapeutics Plc
20 Apr 23
Prospectus supplement
4:32pm
of the Merger
Governance Matters After the Merger
Ownership of the Combined Company
Voting Power in the Combined Company
Regulatory Approvals … /prospectus titled “Interests of TCR2 Directors and Executive Officers in the Merger.”
Governance Matters After the Merger (Page 102)
Pursuant
S-4/A
sp0e r0cudui524ng
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
mw6uwncl
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
r8i4ubgi sq
8 Apr 20
Departure of Directors or Certain Officers
8:06am